Literature DB >> 23490426

A survey of obstetricians' views on placental pathology reporting.

Colin A Walsh1, Fionnuala M McAuliffe, Gitta Turowski, Borghild Roald, Eoghan E Mooney.   

Abstract

OBJECTIVE: To determine the opinion of clinical obstetricians regarding interpretation of placental reports, including a recently proposed Norwegian classification system.
METHODS: Paper and online surveys were circulated to practicing obstetricians in Ireland. Data on clinician experience, clinical workload, and exposure to placental pathology reporting were collated. Additionally, clinicians' opinions regarding the Norwegian classification system were sought. Statistical analysis was performed using Statsdirect version 2.7.8.
RESULTS: Sixty-two practicing clinical obstetricians completed the survey. Overall, 47 (75.8%) respondents had at least 5 years of experience in clinical obstetrics. The population surveyed had a high level of clinicopathologic exposure, with 55 (88.7%) regularly attending a perinatal morbidity conference and 57 (91.9%) reading placental pathology reports. A significantly higher proportion of experienced clinicians read placental pathology reports (46/47 [97.9%]) compared with clinicians with less experience (11/15 [73.3%]; P=0.01). Overall, 51 (82.3%) obstetricians believed that introduction of the Norwegian classification would improve interpretation of placental findings; this high acceptance rate was similar for both experienced and less experienced clinicians (P>0.99).
CONCLUSION: The Norwegian classification system is a clinician-friendly system for placental pathology reporting.
Copyright © 2013 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.

Mesh:

Year:  2013        PMID: 23490426     DOI: 10.1016/j.ijgo.2013.01.008

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  1 in total

1.  Pathologic examination of the placenta and its benefits in treatment plan or follow-up of patients: a cross-sectional study.

Authors:  Setareh Akhavan; Sedigheh Borna; Alireza Abdollahi; Mamak Shariat; Narges Zamani
Journal:  Eur J Med Res       Date:  2022-07-11       Impact factor: 4.981

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.